CAMPath and BELimumab for Transplant Tolerance in Sensitized Kidney Transplant Recipients
Clinical trial NCT03591380 · TERMINATED
Trial details
- NCT number
- NCT03591380
- Sponsor
- University of Wisconsin, Madison
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-14
- Primary completion
- 2021-12-03
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.